Cordycepin’s anti-leukemic effect in U937 and K562 cells was achieved through the reduced attachment of leukemia cells to MSC by decreasing N-cadherin expression on leukemia cells and vascular cell adhesion molecule-1 (VCAM-1) in MSCs (101). This evidence concerns the gene VCAM1 and leukemia.